國立虎尾科技大學 |

Breast cancer genetics, immunology, and immunotherapy = an interdisciplinary approach /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Breast cancer genetics, immunology, and immunotherapy/ edited by Nima Rezaei.
其他題名:	an interdisciplinary approach /
其他作者:	Rezaei, Nima.
出版者:	Cham :Springer Nature Switzerland : : 2024.,
面頁冊數:	xi, 435 p. :ill. (chiefly col.), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Immunotherapy. -
電子資源:	https://doi.org/10.1007/978-3-031-65808-2
ISBN:	9783031658082

Breast cancer genetics, immunology, and immunotherapy = an interdisciplinary approach /
Breast cancer genetics, immunology, and immunotherapyan interdisciplinary approach /[electronic resource] :edited by Nima Rezaei. - Cham :Springer Nature Switzerland :2024. - xi, 435 p. :ill. (chiefly col.), digital ;24 cm. - Interdisciplinary cancer research,v. 62731-457X ;. - Interdisciplinary cancer research ;v. 1..

Role of miRNAs in Triple-Negative Breast Cancer: Diagnosis, Prognosis, and Treatment -- Approaches to Breast Cancer Immunology and Immunotherapy -- Molecular Genetics of Breast Cancer: From Mechanistic Insights to the Therapeutic Approaches -- Interleukins in the Development and Progression of Breast Cancer -- Shaping of the Immune Landscape by Chemokine Receptors that Impacts the Clinical Outcome in Triple-Negative Breast Cancer -- The Prognostic Impact of Tumor-Infiltrated Lymphocytes (TILs) in Breast Cancer -- From Genes to Recovery: Precision Medicine and Its Influence on Multidrug Resistant Breast Cancer -- Recent Progress and Prospects of Immunotherapy in Multidrug-Resistant and Metastatic Breast Cancer Treatment -- Targeting Myeloid Determinants of Breast Cancer -- siRNA Loaded in Drug Delivery Nanosystems as a Strategy for Breast Cancer Treatment -- Nucleic Acid and Drug Dual Agent Nanoplatforms for Breast Cancer -- Oncolytic Virotherapy Against Breast Cancer -- Overcoming Breast Cancer Resistance to Targeted, Chemo-, and Immuno Therapy: Mechanisms and Strategies to Overcome Resistance and Facilitate Drug Development.

Genetics have a role in the presence of breast cancer, while the potential role of the immune system leads to consideration of immunotherapy in the treatment of the disease, particularly in metastatic triple-negative breast cancer. The sixth volume of the "Interdisciplinary Cancer Research" series, entitled "Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach" publishes comprehensive volumes on immune and genetic mechanisms of breast cancer diagnosis and prognosis. The role of molecular genetics, interleukins, chemokine receptor, and tumor-infiltrated lymphocytes-TILS in breast cancer are explained. Targeting myeloid determinants, SiRNA loaded in drug delivery nanosystems, nucleic acid and drug dual agent nanoplatforms, and oncolytic virotherapy are also discussed in the treatment of breast cancer, particularly in multidrug resistant and metastatic breast cancer. This interdisciplinary series is of special value to researchers working on immunology, genetics, and practitioners working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN) This interdisciplinary book will be of special value to researchers, oncologists, geneticists, and immunologists who wish to extend their knowledge on breast cancer.

ISBN: 9783031658082

Standard No.: 10.1007/978-3-031-65808-2doiSubjects--Topical Terms:

592896
Immunotherapy.

LC Class. No.: RC280.B8

Dewey Class. No.: 616.99449

Breast cancer genetics, immunology, and immunotherapy = an interdisciplinary approach /
LDR:03594nam a2200337 a 4500 001 1133568
003 DE-He213
005 20240719130219.0
006 m d
007 cr nn 008maaau
008 241213s2024 sz s 0 eng d
020 $a 9783031658082 $q (electronic bk.)
020 $a 9783031658075 $q (paper)
024 7 $a 10.1007/978-3-031-65808-2 $2 doi
035 $a 978-3-031-65808-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99449 $2 23
090 $a RC280.B8 $b B828 2024
245 0 0 $a Breast cancer genetics, immunology, and immunotherapy $h [electronic resource] : $b an interdisciplinary approach / $c edited by Nima Rezaei.
260 $a Cham : $c 2024. $b Springer Nature Switzerland : $b Imprint: Springer,
300 $a xi, 435 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
490 1 $a Interdisciplinary cancer research, $x 2731-457X ; $v v. 6
505 0 $a Role of miRNAs in Triple-Negative Breast Cancer: Diagnosis, Prognosis, and Treatment -- Approaches to Breast Cancer Immunology and Immunotherapy -- Molecular Genetics of Breast Cancer: From Mechanistic Insights to the Therapeutic Approaches -- Interleukins in the Development and Progression of Breast Cancer -- Shaping of the Immune Landscape by Chemokine Receptors that Impacts the Clinical Outcome in Triple-Negative Breast Cancer -- The Prognostic Impact of Tumor-Infiltrated Lymphocytes (TILs) in Breast Cancer -- From Genes to Recovery: Precision Medicine and Its Influence on Multidrug Resistant Breast Cancer -- Recent Progress and Prospects of Immunotherapy in Multidrug-Resistant and Metastatic Breast Cancer Treatment -- Targeting Myeloid Determinants of Breast Cancer -- siRNA Loaded in Drug Delivery Nanosystems as a Strategy for Breast Cancer Treatment -- Nucleic Acid and Drug Dual Agent Nanoplatforms for Breast Cancer -- Oncolytic Virotherapy Against Breast Cancer -- Overcoming Breast Cancer Resistance to Targeted, Chemo-, and Immuno Therapy: Mechanisms and Strategies to Overcome Resistance and Facilitate Drug Development.
520 $a Genetics have a role in the presence of breast cancer, while the potential role of the immune system leads to consideration of immunotherapy in the treatment of the disease, particularly in metastatic triple-negative breast cancer. The sixth volume of the "Interdisciplinary Cancer Research" series, entitled "Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach" publishes comprehensive volumes on immune and genetic mechanisms of breast cancer diagnosis and prognosis. The role of molecular genetics, interleukins, chemokine receptor, and tumor-infiltrated lymphocytes-TILS in breast cancer are explained. Targeting myeloid determinants, SiRNA loaded in drug delivery nanosystems, nucleic acid and drug dual agent nanoplatforms, and oncolytic virotherapy are also discussed in the treatment of breast cancer, particularly in multidrug resistant and metastatic breast cancer. This interdisciplinary series is of special value to researchers working on immunology, genetics, and practitioners working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN) This interdisciplinary book will be of special value to researchers, oncologists, geneticists, and immunologists who wish to extend their knowledge on breast cancer.
650 2 4 $a Immunotherapy. $3 592896
650 2 4 $a Tumour Immunology. $3 1393571
650 2 4 $a Oncology. $3 593951
650 2 4 $a Cancer Genetics and Genomics. $3 1391074
650 2 4 $a Cancer Therapy. $3 1389305
650 1 4 $a Cancer Biology. $3 1388882
650 0 $a Breast $x Cancer $x Immunological aspects. $3 1072559
650 0 $a Breast $x Cancer $x Genetic aspects. $3 778267
700 1 $a Rezaei, Nima. $3 882367
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a Interdisciplinary cancer research ; $v v. 1. $3 1416733
856 4 0 $u https://doi.org/10.1007/978-3-031-65808-2
950 $a Biomedical and Life Sciences (SpringerNature-11642)